Emborg Marina E
Preclinical Parkinson's Research Program, Wisconsin National Primate Research Center.
Department of Medical Physics, University of Wisconsin, Madison, Wisconsin.
ILAR J. 2017 Dec 1;58(2):190-201. doi: 10.1093/ilar/ilx021.
Alzheimer's (AD), Huntington's (HD), and Parkinson's (PD) disease are age-related neurodegenerative disorders characterized by progressive neuronal cell death. Although each disease has particular pathologies and symptoms, accumulated evidence points to similar mechanisms of neurodegeneration, including inflammation, oxidative stress, and protein aggregation. A significant body of research is ongoing to understand how these pathways affect each other and what ultimately triggers the onset of the disease. Experiments in nonhuman primates (NHPs) account for only 5% of all research in animals. Yet the impact of NHP studies for clinical translation is much greater, especially for neurodegenerative disorders, as NHPs have a complex cognitive and motor functions and highly developed neuroanatomy. New NHP models are emerging to better understand pathology and improve the platform in which to test novel therapies. The goal of this report is to review NHP models of AD, HD, and PD in the context of the current understanding of these diseases and their contribution to the development of novel therapies.
阿尔茨海默病(AD)、亨廷顿舞蹈病(HD)和帕金森病(PD)是与年龄相关的神经退行性疾病,其特征是神经元细胞进行性死亡。尽管每种疾病都有特定的病理学特征和症状,但越来越多的证据表明神经退行性变的机制相似,包括炎症、氧化应激和蛋白质聚集。目前正在进行大量研究,以了解这些途径如何相互影响以及最终是什么引发了疾病的发作。非人灵长类动物(NHP)实验仅占所有动物研究的5%。然而,NHP研究对临床转化的影响要大得多,尤其是对于神经退行性疾病,因为NHP具有复杂的认知和运动功能以及高度发达的神经解剖结构。新的NHP模型正在出现,以更好地理解病理学并改进测试新疗法的平台。本报告的目的是在当前对这些疾病的理解及其对新疗法开发的贡献的背景下,综述AD、HD和PD的NHP模型。